Exploring glutamine as a fuel source for eye cells
Glutamine as an alternative fuel source for photoreceptors
This study is looking at how certain eye cells can use a substance called glutamine for energy when food is low, with the hope of finding new ways to keep these cells healthy and prevent vision loss for people with conditions like age-related macular degeneration.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10892128 on NIH RePORTER |
What this research studies
This research investigates how photoreceptor cells in the eye can use glutamine as an alternative energy source, especially during times when nutrients are scarce. By understanding the metabolic processes of these cells, the study aims to uncover new ways to protect them from death, which is a leading cause of vision loss in conditions like age-related macular degeneration. The research involves laboratory experiments to track how glutamine affects cell survival and function. Ultimately, the goal is to develop new therapies that could help preserve vision for patients suffering from retinal disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing vision loss due to retinal disorders, particularly age-related macular degeneration.
Not a fit: Patients with retinal conditions unrelated to photoreceptor cell death may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent vision loss in patients with retinal diseases.
How similar studies have performed: Other research has shown promise in using alternative fuel sources for cell survival, making this approach a potentially valuable avenue for further exploration.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Wubben, Thomas Joseph — University of Michigan at Ann Arbor
- Study coordinator: Wubben, Thomas Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.